Author:
Miron Victor Daniel,Săndulescu Oana,Streinu-Cercel Anca,Florea Dragoș,Paraschiv Simona,Bănică Leontina,Vlaicu Ovidiu,Oțelea Dan,Bilașco Anuța,Pițigoi Daniela,Streinu-Cercel Adrian,Drăgănescu Anca Cristina
Abstract
AbstractInfluenza viruses are responsible for a high number of infections and hospitalizations every year. In this study, we aimed to identify clinical and host-specific factors that influence the duration of hospitalization and the progression to acute respiratory failure (ARF) in influenza. We performed an analysis of data from a prospective active influenza surveillance study that was conducted over five seasons (2018/19 to 2022/23). A total of 1402 patients with influenza were included in the analysis, the majority of which (64.5%) were children (under 18 years), and 9.1% were elderly. At least one chronic condition was present in 29.2% of patients, and 9.9% of patients developed ARF. The median hospital stay was 4 days (IQR: 3, 6 days). The most important predictors of prolonged hospital stay and development of ARF were extremes of age (infants and elderly), presence of chronic diseases, particularly the cumulus of at least 3 chronic diseases, and late presentation to hospital. Among the chronic diseases, chronic obstructive pulmonary disease, cardiovascular disease, cancer, diabetes, obesity, and chronic kidney disease were strongly associated with a longer duration of hospitalization and occurrence of ARF. In this context, interventions aimed at chronic disease management, promoting influenza vaccination, and improving awareness and access to health services may contribute to reducing the impact of influenza not only in Romania but globally. In addition, continued monitoring of the circulation of influenza viruses is essential to limit their spread among vulnerable populations.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Lafond, K. E. et al. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 18(3), e1003550 (2021).
2. European Centre for Disease Prevention and Control. Risk groups for severe influenza 2023 [accessed: 30 November 2023]. https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups.
3. Centers for Disease Control and Prevention. People at Higher Risk of Flu Complications 2023 [accessed: 30 November 2023]. https://www.cdc.gov/flu/highrisk/index.htm.
4. Chow, E. J. et al. Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale. PLOS ONE. 16(10), e0258482 (2021).
5. Chen, L., Han, X., Li, Y. L., Zhang, C. & Xing, X. FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients. Respir. Res. 21(1), 109 (2020).